(VIANEWS) – SSR Mining (SSRM), Agree Realty Corporation (ADC), Royalty Pharma (RPRX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SSR Mining (SSRM)
40.8% sales growth and 5.57% return on equity
SSR Mining Inc., together with its subsidiaries, engages in the acquisition, exploration, development, and operation of precious metal resource properties in Turkey and the Americas. The company explores for gold, silver, copper, lead, and zinc deposits. Its projects include the Çöpler Gold mine located in Erzincan, Turkey; the Marigold mine located in Humboldt County, Nevada, the United States; the Seabee Gold Operation located in Saskatchewan, Canada; and the Puna Operations in Jujuy, Argentina. The company was formerly known as Silver Standard Resources Inc. and changed its name to SSR Mining Inc. in August 2017. SSR Mining Inc. was incorporated in 1946 and is based in Denver, Colorado.
Earnings Per Share
As for profitability, SSR Mining has a trailing twelve months EPS of $1.
PE Ratio
SSR Mining has a trailing twelve months price to earnings ratio of 11.69. Meaning, the purchaser of the share is investing $11.69 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.57%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 9, 2023, the estimated forward annual dividend rate is 0.28 and the estimated forward annual dividend yield is 2.4%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 500% and 191.7%, respectively.
Sales Growth
SSR Mining’s sales growth is 130.8% for the ongoing quarter and 40.8% for the next.
2. Agree Realty Corporation (ADC)
17.8% sales growth and 3.38% return on equity
Earnings Per Share
As for profitability, Agree Realty Corporation has a trailing twelve months EPS of $1.7.
PE Ratio
Agree Realty Corporation has a trailing twelve months price to earnings ratio of 33.32. Meaning, the purchaser of the share is investing $33.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.38%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 8.7% and a negative 4.5%, respectively.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Oct 29, 2023, the estimated forward annual dividend rate is 2.96 and the estimated forward annual dividend yield is 5.23%.
3. Royalty Pharma (RPRX)
10.8% sales growth and 4.66% return on equity
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Earnings Per Share
As for profitability, Royalty Pharma has a trailing twelve months EPS of $0.39.
PE Ratio
Royalty Pharma has a trailing twelve months price to earnings ratio of 68.49. Meaning, the purchaser of the share is investing $68.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.66%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Nov 15, 2023, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 2.86%.
Volume
Today’s last reported volume for Royalty Pharma is 1520280 which is 30.79% below its average volume of 2196720.
Sales Growth
Royalty Pharma’s sales growth is 4.6% for the present quarter and 10.8% for the next.
4. RCI Hospitality Holdings (RICK)
10.4% sales growth and 14.64% return on equity
RCI Hospitality Holdings, Inc., through its subsidiaries, engages in the hospitality and related businesses in the United States. The company operates through Nightclubs, Bombshells, and Other segments. It owns and/or operates upscale adult nightclubs serving primarily businessmen and professionals under the Rick's Cabaret, Jaguars Club, Tootsie's Cabaret, XTC Cabaret, Club Onyx, Hoops Cabaret and Sports Bar, Scarlett's Cabaret, Temptations Adult Cabaret, Foxy's Cabaret, Vivid Cabaret, Downtown Cabaret, Cabaret East, The Seville, Silver City Cabaret, and Kappa Men's Club. The company also operates restaurants and sports bars under the Bombshells Restaurant & Bar brand, as well as a dance club under the Studio 80 brand. In addition, it owns two national industry trade publications serving the adult nightclubs industry and the adult retail products industry; a national industry convention and tradeshow; and two national industry award shows, as well as approximately a dozen industry and social media Websites. Further, RCI Hospitality Holdings, Inc. holds license to sell Robust Energy Drink in the United States. The company was formerly known as Rick's Cabaret International, Inc. and changed its name to RCI Hospitality Holdings, Inc. in August 2014. RCI Hospitality Holdings, Inc. was founded in 1983 and is based in Houston, Texas.
Earnings Per Share
As for profitability, RCI Hospitality Holdings has a trailing twelve months EPS of $4.06.
PE Ratio
RCI Hospitality Holdings has a trailing twelve months price to earnings ratio of 13.9. Meaning, the purchaser of the share is investing $13.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.64%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 10.3% and a negative 4.2%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9%, now sitting on 289.92M for the twelve trailing months.
5. Autodesk (ADSK)
8.7% sales growth and 89.82% return on equity
Autodesk, Inc. provides 3D design, engineering, and entertainment technology solutions worldwide. The company offers AutoCAD Civil 3D, a surveying, design, analysis, and documentation solution for civil engineering, including land development, transportation, and environmental projects; BuildingConnected, a SaaS preconstruction solution; AutoCAD, a software for professional design, drafting, detailing, and visualization; AutoCAD LT, a drafting and detailing software; computer-aided manufacturing (CAM) software for computer numeric control machining, inspection, and modelling for manufacturing; Fusion 360, a 3D CAD, CAM, and computer-aided engineering tool; and Industry Collections tools for professionals in architecture, engineering and construction, product design and manufacturing, and media and entertainment collection industries. It also provides Inventor tools for 3D mechanical design, simulation, analysis, tooling, visualization, and documentation; Vault, a data management software to manage data in one central location, accelerate design processes, and streamline internal/external collaboration; Maya and 3ds Max software products that offer 3D modeling, animation, effects, rendering, and compositing solutions; and ShotGrid, a cloud-based software for review and production tracking in the media and entertainment industry. It sells its products and services to customers directly, as well as through a network of resellers and distributors. Autodesk, Inc. was incorporated in 1982 and is headquartered in San Francisco, California.
Earnings Per Share
As for profitability, Autodesk has a trailing twelve months EPS of $4.03.
PE Ratio
Autodesk has a trailing twelve months price to earnings ratio of 51.87. Meaning, the purchaser of the share is investing $51.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 89.82%.
Volume
Today’s last reported volume for Autodesk is 326980 which is 73.24% below its average volume of 1222280.
6. AptarGroup (ATR)
6.6% sales growth and 13.72% return on equity
AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active packaging products. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup, Inc. has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. The company was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Earnings Per Share
As for profitability, AptarGroup has a trailing twelve months EPS of $3.78.
PE Ratio
AptarGroup has a trailing twelve months price to earnings ratio of 33.02. Meaning, the purchaser of the share is investing $33.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.72%.
Volume
Today’s last reported volume for AptarGroup is 238636 which is 25.03% below its average volume of 318348.
